相关实验视频

Updated: Jan 12, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

基因组可操作性和匹配的向疗法在为期十年的实体精密医学计划中用于固体瘤

R Dienstmann¹, A Vivancos², P Nuciforo²

¹Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain.

|November 7, 2025

概括

精密瘤学计划在十年内显著改善了可操作的变异检测和匹配的治疗机会. 诊断和试验的持续创新对于推进癌症治疗至关重要.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
翻译医学是一种翻译医学.

背景情况:

精密瘤学已经推进了癌症治疗,但在基因组分析和治疗准入方面面临着差异.
希伯伦谷瘤研究所 (Vall d'Hebron Institute of Oncology,简称VHIO) 建立了一个精准医学计划 (PMP),以应对这些挑战.

研究的目的:

评估VHIO PMP在十年 (2014-2024) 的表现.
评估可操作的变异检测和匹配疗法的利用趋势.

主要方法:

在VHIO PMP (2014-2024) 中对患者的回顾性分析.
对瘤分析结果的审查,重点关注欧洲医学瘤学会分子标临床可操作性尺度 (ESCAT) 分类.
通过多学科分子瘤委员会进行标准化解释和治疗优先级.
关键绩效指标 (KPIs) 包括检测ESCAT级别I-IV变化和接受匹配疗法.

主要成果:

在12,168名患者中分析了超过13,700个分子概况.
可采取行动的变异检测率从10.1% (2014) 增加到53.1% (2024).
分子匹配疗法的使用率从1% (2014) 增加到14.2% (2024),其中23.5%的可操作变化的患者接受了向治疗.
液体活检提高了检测和治疗准入;临床试验资格标准得到了改进.

结论:

VHIO PMP在可操作的改变检测和匹配治疗提供方面取得了成功.
有关关键指标监测的综合计划对于精密瘤学的持续表现至关重要.
诊断和分子导向临床试验的持续进步对于未来的进步至关重要.

关键词:

可以采取行动的可行性.匹配的疗法相匹配的疗法分子试验分子试验绩效指标绩效指标绩效指标精确瘤学精确瘤学

更多相关视频

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...